MoneyWorks4Me

Cipla informs about press release

02 Apr 2020 Evaluate

Cipla has informed that the company has enclosed a press release dated 2nd April 2020 regarding ‘Cipla announces successful completion of Phase-3 clinical study for generic version of GSK’s Advair Diskus’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..